A Randomized Controlled Trial Assessing the Effects of a Pharmacist-Led Educational Pharmaceutical Care Program on Clinical and Self-Management Outcomes in Type 2 Diabetes Mellitus Patients in Gujarat, India
1, 2
- 1Department of Pharmacology, Indukaka Ipcowala College of Pharmacy, New V.V. Nagar, The Charutar Vidya Mandal University, Anand, Gujarat, INDIA.
- 2Indukaka Ipcowala College of Pharmacy, New V.V. Nagar, The Charutar Vidya Mandal University, Anand, Gujarat, INDIA.
CORRESPONDENCE
Rishita. D Patel
Department of Pharmacology, Indukaka Ipcowala College of Pharmacy, New V.V. Nagar, The Charutar Vidya Mandal University, Anand, Gujarat, INDIA.
Received: 11-01-2026; Accepted: 21-04-2026.
Volume 60, Issue 3s (Supplement) · pp. s1331-s1340 · 2026 · DOI: 10.5530/ijper.20263193
ABSTRACT
Objectives: The objective of the pharmacist-led educational Pharmaceutical Care Intervention Program (PLEPCIP) was to evaluate its effect on glycemic control, as measured by HbA1c levels, in patients with type 2 diabetes. Secondary outcomes included changes in blood pressure, lipid profile, body weight, medication adherence (assessed using the MMAS-4 scale), and self-management behaviors such as physical activity and dietary practices.Materials and Methods: Study was a prospective and longitudinal randomized controlled trial conducted in patients with type 2 diabetes at the OPD of a private diabetic hospital. A total of 280 patients enrolled; of these, n=139 patients were randomized to the Control Group (CG) and n=141 to the Interventional Group (IG). The duration of the present study was 16 months with 4 follow-up discussion sessions. Study outcome was measured at multiple visits, including baseline week 0 and follow-up weeks 16, 32, 48, and 64.Results: Patients in the intervention group demonstrated a statistically significant reduction in glycated hemoglobin (HbA1C) levels compared to the control group (mean reduction: 1.1% vs. 0.03%; p<0.001). Additionally, the intervention group exhibited significant improvements in Body Mass Index (BMI; p=0.049), systolic blood pressure (SBP; p=0.015), and Diastolic Blood Pressure (DBP; p=0.030). Triglyceride concentrations also decreased significantly within the intervention cohort (p=0.003). Furthermore, participants in the intervention group reported enhanced self-management behaviors, characterized by increased engagement in physical activity and adherence to a balanced dietary regimen. Medication adherence, as assessed by the Morisky Medication Adherence Scale, showed significant improvement (p<0.001), indicating better compliance with prescribed therapeutic protocols.Conclusion: A greater reduction in the HbA1C with overall metabolic outcomes was significantly associated with the clinical pharmacist-led educational Pharmaceutical Care Intervention Program (PLEPCIP) in type 2 diabetes mellitus patients.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Patel, R. D., & Patel, H. V. (2026). A Randomized Controlled Trial Assessing the Effects of a Pharmacist-Led Educational Pharmaceutical Care Program on Clinical and Self-Management Outcomes in Type 2 Diabetes Mellitus Patients in Gujarat, India. Indian Journal of Pharmaceutical Education and Research, 60(3s), s1331-s1340. https://doi.org/10.5530/ijper.20263193
Copyright and licence
© 2026 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0